ArticleExpert opinion on therapeutic targets2015

Targeting α-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies.

Simon Moussaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.